Acumetis Launches as Integrated Brand for Life Sciences Commercialization

Five leading consultancies combine to create full-service commercialization powerhouse for biopharma industry.

Apr. 15, 2026 at 3:40pm

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life photograph featuring a collection of premium, polished geometric objects in shades of blue, grey, and white, conceptually representing the integrated commercial services and data-driven insights that Acumetis provides to the life sciences industry.Acumetis' integrated commercialization model and data-driven insights aim to provide life sciences companies with the strategic clarity needed to navigate complex product development and launch challenges.Yardley Today

Five leading life sciences organizations - Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group - have come together as a single integrated brand called Acumetis to support better decision-making across the entire biopharma product lifecycle. The new global commercialization company for the life sciences industry will provide enhanced strategic clarity and critical connection for life sciences businesses with products at all stages of development.

Why it matters

The landmark move is inspired by the need to provide a new level of counsel and enhanced strategic clarity to clients operating in an age of complexity and rapid evolution in the life sciences industry. The combined businesses bring together over 350 experts across multiple countries to cover the full spectrum of commercial strategy, launch excellence, patient access, value and access, insights and analytics, and medical affairs.

The details

Acumetis is built around a single integrated commercial model and one leadership team, bringing together commercial, insights, medical, market access and patient strategy under one roof. The business offers capability and data to support clients across the product lifecycle, from evaluation and market access strategy through to launch execution and in-market performance. Acumetis is headquartered in Yardley, Pennsylvania, with additional offices across the United States, Canada, South America, United Kingdom, Europe and India.

  • Acumetis launches on April 14, 2026.

The players

Acumetis

A new global commercialization company for the life sciences industry, formed as a combination of five well-known specialist consultancies - Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group.

Brent Herspiegel

CEO of Acumetis.

DFW Capital Partners

An established middle-market private equity firm investing in companies that provide outsourced business, industrial, or healthcare services in regulated, compliance driven end-markets, and the firm backing Acumetis.

Got photos? Submit your photos here. ›

What they’re saying

“Acumetis is designed to set a new standard in commercialization. Not just in capability, but in how that capability is delivered. For over two decades, the businesses that form Acumetis have supported more than 200 product launches for some of the most complex and high-stakes assets in life sciences. We're now bringing our clients our full expertise as one integrated brand, helping them to make the right decision at the moments that matter most. For life sciences companies facing compressed timelines, increasing regulatory complexity and rising pressure to demonstrate value, this is a compelling value proposition.”

— Brent Herspiegel, CEO of Acumetis

What’s next

Acumetis will continue to expand its global footprint and service offerings to support the evolving needs of the life sciences industry.

The takeaway

The creation of Acumetis as a single integrated brand represents a strategic milestone for the life sciences commercialization industry, bringing together deep expertise and resources to provide enhanced strategic clarity and critical connection for clients navigating the complexities of modern biopharma product development and launch.